Targeted manipulation of MEF2C alleviates negative affect and anxiety-like behaviors while restoring dopaminergic neurotransmission, establishing MEF2C as a key molecular regulator linking long-term nerve injury to maladaptive reward circuitry and affective dysfunction. The gene discussed is MEF2C; the disease is Anxiety.